Related Experiment Video
Updated: May 18, 2026
04:37
Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
Published on: May 23, 2025
G protein-coupled receptor-mediated platelet thrombus formation
1Cardeza Foundation of Hematologic Research, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Current Opinion in Hematology
|May 16, 2026
Summary
Platelet G protein-coupled receptor (GPCR) signaling is crucial for blood clots. New insights show its regulation is dynamic and context-dependent, influencing targeted antithrombotic therapies.
Area of Science:
- Cardiovascular Biology
- Hematology
- Pharmacology
Background:
- Platelet G protein-coupled receptor (GPCR) signaling is vital for platelet activation and thrombus formation.
- Current understanding often relies on simplified models, not fully reflecting in vivo, vascular bed-specific regulation.
Purpose of the Study:
- To review recent advances in platelet GPCR regulatory mechanisms, including GPCR kinases (GRKs) and biased signaling.
- To discuss challenges in modeling human thrombin/PAR signaling due to interspecies differences.
Main Methods:
- Review of recent scientific literature on platelet GPCR signaling.
- Analysis of findings related to vascular bed specificity, platelet heterogeneity, and procoagulant platelets.
Main Results:
- Platelets have distinct roles in arterial vs. venous thrombosis.
- Platelet heterogeneity and procoagulant platelets link coagulation and thromboinflammation.
- Platelet GPCR signaling is dynamic and context-dependent, influenced by vascular cues and thrombus organization.
Conclusions:
- Spatiotemporal regulation of platelet GPCR signaling offers a framework for understanding hemostasis and thrombosis.
- This understanding may guide the development of selective antithrombotic strategies targeting GPCR effectors or biased signaling while preserving hemostasis.
Related Concept Videos
01:22Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:18Structure and Function of Platelets
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
01:16Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
01:17Intracellular Signaling Affects Focal Adhesions
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...